Survival after amphotericin B overdose treated with plasmapheresis

Annals of Pharmacotherapy

Volumn 47, Issue 2, 2013, Pages

  Wang, George Sam ^a   Banerji, Shireen ^a   Keith Roussil, T ^a   Heard, Kennon J ^a,b  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CONGENITAL DISORDER; DRUG BLOOD LEVEL; DRUG OVERDOSE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MALAISE; MEDICAL HISTORY; MEDICATION ERROR; MYCOSIS; PLASMAPHERESIS; PRIORITY JOURNAL;

EID: 84873973233     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R527     Document Type: Article

References (12)

1. Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999;12:501-17.
2. Burke D, Lai R, Finkel KW, Samuels J, Foringer JR. Acute amphotericin B overdose. Ann Pharmacother 2006;40:2254-2259. doi: 10.1345/aph.1H157
3. Cleary JD, Hayman J, Sherwood J, Lasala GP, Piazza-Hepp T. Amphotericin B overdose in pediatric patients with associated cardiac arrest. Ann Pharmacother 1993;27:715-9.
4. Groeneveld S, Verwei PE, Van't Hek L, Bokkernick JP, Warris A. Amphotericin B-deoxycholate overdose due to administration error in pediatrics patients. Med Mycol 2008;46:185-7.
5. Koren G, Lau A, Kenyon CF, Kroppert D, Klein J. Clinical course and pharmacokinetics following a massive overdose of amphotericin B in a neonate. Clin Toxicol 1990;28:371-8.
6. Mohr JF, Hall AC, Ericsson CD, Ostrocky-Zeichner L. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation. Pharmacotherapy 2005;25:426-8.
7. Perlman JM, Acarregui M, Gard JW. Fatal overdose of amphotericin B in two preterm infants. Dev Pharmacol Ther 1991;17:187-90.
8. Gussak HM, Rahman S, Bastani B. Administration and clearance of amphotericin B during high-efficiency or high-efficiency/high-flux dialysis. Am J Kidney Dis 2001;27:E45.
9. Summers KK, Hardin TC, Gore SJ, Graybill JR. Therapeutic drug monitoring of systemic antifungal therapy. J Antimicrob Chemother 1997;40: 753-64.
10. Ibrahim RB, Liu C, Cronin S, et al. Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy 2007;27:1529-49.
11. Butler ST, Bennet JE, Hill GJ, Szwed CF, Cotlove E. Electrocardiographic and electrolyte abnormalities caused by amphotericin B in dog and man. Proc Soc Exp Biol Med 1964;116:857-63.
12. Atkinson AJ, Bennett JE. Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother 1978;13:271-6.